β2-Adrenergic receptor regulate Toll-like receptor 4-induced late-phase NF-κB activation

Molecular Immunology

Volumn 46, Issue 6, 2009, Pages 1195-1203

  Kizaki, Takako ^a   Shirato, Ken ^a   Sakurai, Takuya ^a   Ogasawara, Jun etsu ^a   Oh ishi, Shuji ^b   Matsuoka, Takeshi ^b   Izawa, Tetsuya ^c   Imaizumi, Kazuhiko ^d   Haga, Shukoh ^e   Ohno, Hideki ^a  

^a KYORIN UNIVERSITY   (Japan)

^b TOKYO MEDICAL UNIVERSITY   (Japan)

^c DOSHISHA UNIVERSITY   (Japan)

^d WASEDA UNIVERSITY   (Japan)

^e UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Arrestin 2; 2 Adrenergic receptor; I B ; Inducible nitric oxide synthase; Lipopolysaccharide; Macrophages; NF B; Toll like receptor 4

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; BETA ARRESTIN 2; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; MYELOID DIFFERENTIATION FACTOR 88; SMALL INTERFERING RNA; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1; BETA ARRESTIN; RETINA S ANTIGEN; TICAM 1 PROTEIN, MOUSE; TICAM-1 PROTEIN, MOUSE; TLR4 PROTEIN, MOUSE; VESICULAR TRANSPORT ADAPTOR PROTEIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GENE LOCUS; GENETIC TRANSCRIPTION; IMMUNOREGULATION; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RECEPTOR DOWN REGULATION; SIGNAL TRANSDUCTION; ANIMAL; CELL LINE; DOWN REGULATION; GENE SILENCING; GENETICS; IMMUNOLOGY; METABOLISM; PHYSIOLOGY;

ADAPTOR PROTEINS, VESICULAR TRANSPORT; ANIMALS; ARRESTINS; CELL LINE; DOWN-REGULATION; GENE KNOCKDOWN TECHNIQUES; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; MYELOID DIFFERENTIATION FACTOR 88; NF-KAPPA B; NITRIC OXIDE SYNTHASE TYPE II; RECEPTORS, ADRENERGIC, BETA-2; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4;

EID: 60949101623     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2008.11.005     Document Type: Article

References (42)

1. Adachi O., Kawai T., Takeda K., Matsumoto M., Tsutsui H., Sakagami M., Nakanishi K., and Akira S. Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity 9 (1998) 143-150
2. Akira S., and Takeda K. Toll-like receptor signalling. Nat. Rev. Immunol. 4 (2004) 499-511
3. Alexopoulou L., Holt A.C., Medzhitov R., and Flavell R.A. Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3. Nature 413 (2001) 732-738
4. Arenzana-Seisdedos F., Turpin P., Rodriguez M., Thomas D., Hay R.T., Virelizier J.L., and Dargemont C. Nuclear localization of I kappa B alpha promotes active transport of NF-kappa B from the nucleus to the cytoplasm. J. Cell Sci. 110 Pt 3 (1997) 369-378
5. Barlic J., Andrews J.D., Kelvin A.A., Bosinger S.E., DeVries M.E., Xu L., Dobransky T., Feldman R.D., Ferguson S.S., and Kelvin D.J. Regulation of tyrosine kinase activation and granule release through β-arrestin by CXCRI. Nat. Immunol. 1 (2000) 227-233
6. Bauer S., Kirschning C.J., Hacker H., Redecke V., Hausmann S., Akira S., Wagner H., and Lipford G.B. Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 9237-9242
7. Bogdan C. Nitric oxide and the immune response. Nat. Immunol. 2 (2001) 907-916
8. 2-adrenergic receptor mRNA stability occurs via a specific AU-rich element. J. Biol. Chem. 273 (1998) 3223-3229
9. Ding A.H., Nathan C.F., and Stuehr D.J. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. J. Immunol. 141 (1988) 2407-2412
10. Downing J.E., and Miyan J.A. Neural immunoregulation: emerging roles for nerves in immune homeostasis and disease. Immunol. Today 21 (2000) 281-289
11. Elenkov I.J., Wilder R.L., Chrousos G.P., and Vizi E.S. The sympathetic nerve-an integrative interface between two supersystems: the brain and the immune system. Pharmacol. Rev. 52 (2000) 595-638
12. Fong A.M., Premont R.T., Richardson R.M., Yu Y.R., Lefkowitz R.J., and Patel D.D. Defective lymphocyte chemotaxis in β-arrestin2- and GRK6-deficient mice. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 7478-7483
13. Gao H., Sun Y., Wu Y., Luan B., Wang Y., Qu B., and Pei G. Identification of beta-arrestin2 as a G protein-coupled receptor-stimulated regulator of NF-κB pathways. Mol. Cell 14 (2004) 303-317
14. Gavrilyuk V., Dello Russo C., Heneka M.T., Pelligrino D., Weinberg G., and Feinstein D.L. Norepinephrine increases IκBα expression in astrocytes. J. Biol. Chem. 277 (2002) 29662-29668
15. Hierholzer C., Harbrecht B., Menezes J.M., Kane J., MacMicking J., Nathan C.F., Peitzman A.B., Billiar T.R., and Tweardy D.J. Essential role of induced nitric oxide in the initiation of the inflammatory response after hemorrhagic shock. J. Exp. Med. 187 (1998) 917-928
16. Huang T.T., and Miyamoto S. Postrepression activation of NF-κB requires the amino-terminal nuclear export signal specific to IκBα. Mol. Cell Biol. 21 (2001) 4737-4747
17. 2-adrenergic receptor expression by exercise training increases IL-12 production by macrophages following LPS stimulation. Biochem. Biophys. Res. Commun. 322 (2004) 979-984
18. Janeway Jr. C.A., and Medzhitov R. Innate immune recognition. Annu. Rev. Immunol. 20 (2002) 197-216
19. Kaisho T., Takeuchi O., Kawai T., Hoshino K., and Akira S. Endotoxin-induced maturation of MyD88-deficient dendritic cells. J. Immunol. 166 (2001) 5688-5694
20. Kawai T., Adachi O., Ogawa T., Takeda K., and Akira S. Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 11 (1999) 115-122
21. Kawai T., Takeuchi O., Fujita T., Inoue J., Muhlradt P.F., Sato S., Hoshino K., and Akira S. Lipopolysaccharide stimulates the MyD88-independent pathway and results in activation of IFN-regulatory factor 3 and the expression of a subset of lipopolysaccharide-inducible genes. J. Immunol. 167 (2001) 5887-5894
22. 2-adrenergic receptor regulates Toll-like receptor-4-induced nuclear factor-κB activation through β-arrestin 2. Immunology 124 (2008) 348-356
23. high activated macrophages. J. Leukoc. Biol. 68 (2000) 21-30
24. Kizaki T., Suzuki K., Hitomi Y., Iwabuchi K., Onoé K., Haga S., Ishida H., Ookawara T., Suzuki K., and Ohno H. Negative regulation of LPS-stimulated expression of inducible nitric oxide synthase by AP-1 in macrophage cell line J774A.1. Biochem. Biophys. Res. Commun. 289 (2001) 1031-1038
25. Kizaki T., Suzuki K., Hitomi Y., Taniguchi N., Saitoh D., Watanabe K., Onoé K., Day N.K., Good R.A., and Ohno H. Uncoupling protein 2 plays an important role in nitric oxide production of lipopolysaccharide-stimulated macrophages. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 9392-9397
26. Kizaki T., Takemasa T., Sakurai T., Izawa T., Hanawa T., Kamiya S., Haga S., Imaizumi K., and Ohno H. Adaptation of macrophages to exercise training improves innate immunity. Biochem. Biophys. Res. Commun. 372 (2008) 152-156
27. + T and B lymphocyte function in vitro and in vivo. Pharmacol. Rev. 53 (2001) 487-525
28. Lain de Lera T., Folgueira L., Martin A.G., Dargemont C., Pedraza M.A., Bermejo M., Bonay P., Fresno M., and Alcami J. Expression of IκBα in the nucleus of human peripheral blood T lymphocytes. Oncogene 18 (1999) 1581-1588
29. Luttrell L.M., and Lefkowitz R.J. The role of β-arrestins in the termination and transduction of G-protein-coupled receptor signals. J. Cell Sci. 115 (2002) 455-465
30. Moorthy A.K., and Ghosh G. p105.IκBγ and prototypical IκBs use a similar mechanism to bind but a different mechanism to regulate the subcellular localization of NF-κB. J. Biol. Chem. 278 (2003) 556-566
31. 2 adrenergic receptor mRNA inhibits receptor synthesis. J. Biol. Chem. 269 (1994) 4497-4505
32. Parry G.C., and Mackman N. Role of cyclic AMP response element-binding protein in cyclic AMP inhibition of NF-κB-mediated transcription. J. Immunol. 159 (1997) 5450-5456
33. Perry S.J., and Lefkowitz R.J. Arresting developments in heptahelical receptor signaling and regulation. Trends Cell Biol. 12 (2002) 130-138
34. Prigent M., Barlat I., Langen H., and Dargemont C. IκBα and IκBα/NF-κB complexes are retained in the cytoplasm through interaction with a novel partner, RasGAP SH3-binding protein 2. J. Biol. Chem. 275 (2000) 36441-36449
35. Rodriguez M.S., Thompson J., Hay R.T., and Dargemont C. Nuclear retention of IκBα protects it from signal-induced degradation and inhibits nuclear factor κB transcriptional activation. J. Biol. Chem. 274 (1999) 9108-9115
36. Sun Y., Cheng Z., Ma L., and Pei G. β-arrestin2 is critically involved in CXCR4-mediated chemotaxis, and this is mediated by its enhancement of p38 MAPK activation. J. Biol. Chem. 277 (2002) 49212-49219
37. Takeda K., Kaisho T., and Akira S. Toll-like receptors. Annu. Rev. Immunol. 21 (2003) 335-376
38. Tergaonkar V., Correa R.G., Ikawa M., and Verma I.M. Distinct roles of IκB proteins in regulating constitutive NF-κB activity. Nat. Cell Biol. 7 (2005) 921-923
39. 2-adrenergic receptor mRNA by mutagenesis and identification of the homologous AU-rich region from different species. Biochemistry 38 (1999) 15564-15572
40. Walker J.K., Fong A.M., Lawson B.L., Savov J.D., Patel D.D., Schwartz D.A., and Lefkowitz R.J. β-arrestin-2 regulates the development of allergic asthma. J. Clin. Invest. 112 (2003) 566-574
41. Witherow D.S., Garrison T.R., Miller W.E., and Lefkowitz R.J. β-Arrestin inhibits NF-κB activity by means of its interaction with the NF-κB inhibitor IκBα. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 8603-8607
42. Yamamoto M., Sato S., Hemmi H., Hoshino K., Kaisho T., Sanjo H., Takeuchi O., Sugiyama M., Okabe M., Takeda K., and Akira S. Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science 301 (2003) 640-643